Anti-CXCL1/GRO alpha antibody [EPR23533-315]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CXCL1/GRO alpha antibody. Suitable for IP, WB and reacts with Human, Recombinant fragment - Human samples.
View Alternative Names
GRO, GRO1, GROA, MGSA, SCYB1, CXCL1, Growth-regulated alpha protein, C-X-C motif chemokine 1, GRO-alpha(1-73), Melanoma growth stimulatory activity, Neutrophil-activating protein 3, NAP-3
- IP
Supplier Data
Immunoprecipitation - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (AB307589)
CXCL1/GRO alpha was immunoprecipitated from 0.35 mg HUVEC (human umbilical vein endothelial cell) treated with 0.5µg/ml Lipopolysaccharides(LPS) for 24 hours and then added 300 ng/ml Brefeldin A for another 20 hours, whole cell lysate 10 µg with ab307589 at 1/30 dilution (2 µg in 0.35 mg lysates). Western blot was performed on the immunoprecipitate using ab307589 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : HUVEC treated with 0.5µg/ml Lipopolysaccharides(LPS) for 24 hours and then added 300 ng/ml Brefeldin A for another 20 hours, whole cell lysate 10 µg Lane 2 : ab307589 IP in HUVEC treated with 0.5µg/ml Lipopolysaccharides(LPS) for 24 hours and then added 300 ng/ml Brefeldin A for another 20 hours, whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab307589 in HUVEC treated with 0.5µg/ml Lipopolysaccharides(LPS) for 24 hours and then added 300 ng/ml Brefeldin A for another 20 hours, whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 180 seconds.
All lanes:
Immunoprecipitation - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (ab307589) at 1/30 dilution
All lanes:
HUVEC treated with 0.5ug/ml Lipopolysaccharides
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 11 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (AB307589)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. This antibody does not cross-react with human CXCL2 and CXCL3. Exposure time : 180 seconds.
All lanes:
Western blot - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (ab307589) at 1/1000 dilution
Lane 1:
His-tagged human CXCL1 recombinant protein at 10 ng
Lane 2:
His-tagged human CXCL2 recombinant protein at 10 ng
Lane 3:
His-tagged human CXCL3 recombinant protein at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 11 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (AB307589)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CXCL1/GRO alpha antibody [EPR23533-315] (ab307589) at 1/1000 dilution
Lane 1:
Untreated HUVEC (human umbilical vein endothelial cell) whole cell lysate at 20 µg
Lane 2:
HUVEC treated with 0.5ug/ml Lipopolysaccharides (LPS) for 4 hours and then added 300 ng/ml Brefeldin A for another 20 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 11 kDa
Observed band size: 11 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-CXCL1/GRO alpha antibody [EPR23533-315] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL1 functions as a significant mediator in inflammatory processes. It does not form a complex but acts independently to exert its effects. By attracting neutrophils to sites of injury or infection CXCL1 supports the body's defense mechanisms. This chemokine also influences angiogenesis contributing to the formation of new blood vessels which is essential in wound healing and tissue regeneration.
Pathways
CXCL1 plays a role in both the NF-kB signaling and MAPK signaling pathways. These pathways are pivotal for the regulation of immune and inflammatory responses. CXCL1 acts alongside proteins such as IL-8 another chemokine that also binds to the CXCR2 receptor. Through these pathways CXCL1 influences the activation and migration of immune cells facilitating a rapid response to inflammatory stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com